Jana Wolf

Wissenschaftszentrum Berlin für Sozialforschung gGmbH is a research center based in Berlin, Germany. The German company conducts research in the field of social sciences and aims to clarify positions and sharpen arguments. The company is ultimately controlled by the Government of Germany. The company was founded in 2019, and the CEO is Ursula Noack.

BioM AG Munich BioTech Development (BMBD) is a venture capital firm specialized in the life sciences sector. Located in Martinsried on the outskirts of Munich, BMBD was established in 2002 to manage the investment portfolio of BioM AG, a regional technology transfer and venture capital services company. BioM was created in 1997 following Munich's selection in the Government-sponsored BioRegio Competition, and provides business support services to Munich-based biotechnology companies, focusing on start-ups. BMBD manages the BioM Venture Capital fund. Their clients include regional banks, German and European private equity firms and private individuals. The firm operates in partnership with public entities, in particular the German Federal Ministry of Education and Research (BMBF) and HighTech Gründerfonds (HTGF), a partnership between the Government of Germany, the KfW banking group and leading technology corporations.

Helmholtz-Zentrum Berlin für Materialien und Energie GmbH engages in research activities focusing on energy materials. It operates large-scale scientific research facilities, in order to perform experiments on photovoltaics, solar fuels and catalysis, energy-efficient information technologies, thermoelectrics, electrochemical energy storage, and accelerator development. The firm also provides job training programs. The company was founded on January 1, 2009 and is headquartered in Berlin, Germany.

Max Planck Gesellschaft zur Förderung der Wissenschaften eV (MPG) is a non-profit organization headquartered in Munich, Germany. The firm was founded in 1948 as a successor organization to the Kaiser Wilhelm Society. MPG conducts basic research in the natural sciences, life sciences, and humanities and provides investment advisory services to foundations.

Part of Klinikum der Universitaet Heidelberg, Klinik - Service - Gesellschaft am Universitatsklinikum Heidel is a company based in Heidelberg, Germany. The German company specializes in treating metabolic disorders and related diseases in endocrinology, diabetology, clinical chemistry, and metabolism. The company was founded in 2004. The CEO is Edgar Reisch.

Universitätsklinikum Heidelberg engages in the management and operation of hospitals. It offers medical services in the fields of surgery, neurology, anesthesiology, internal medicine, urology, radiology, psychiatry, orthopedics, nuclear medicine, cardiology, and oncology. The company is headquartered in Heidelberg, Germany.

WZB Berlin Social Science Center is a research center that focuses on innovative and user-oriented services in the field of scientific information. The center is based in Berlin, Germany and was founded in 1969. The center has ongoing projects related to the evaluation of the geographical restructuring of companies and industries in production networks after Covid-19. The center also has a Präsidialbereich that provides administrative and service support. The research program of the center is divided into three main areas, including the analysis of long-term changes in political conflicts. The CEO is Ursula Noack.

Part of Max-Delbrück-Centrum für Molekulare Medizin (MDC), Campus Berlin-Buch GmbH is a company located in Berlin-Buch, Germany. The CEOs of the German company are Christina Quensel, Ulrich Scheller.

German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany.

Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany.

Das Alfred-Wegener-Institut für Polar- und Meeresforschung is based in Bremerhaven, Germany. The German company conducts research in the polar regions and oceans of the middle and high latitudes. It is one of 18 research centers of the Helmholtz Association and coordinates Germany's polar research. The private company provides research vessels like the Polarstern and stations like the Neumayer-Station-III for international scientific use.

Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany.

GNA Biosolutions GmbH develops instruments for molecular pathogen detection. The firm offers PCA technology, lab and portable solutions. The company was founded by Joachim Stehr, Federico Bürsgens and Lars Ullerich in 2010 and is headquartered in Martinsried, Germany.

The Council of European Bioregions is a membership-based biotechnology organization. The Spanish company was founded by Horst Domdey.

BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006.

BioM AG is a regional technology transfer and venture capital services company created in 1997 following Munich's selection in the Government-sponsored BioRegio Competition. The firm provides business support services to Munich-based biotechnology companies, focusing on startups. Through BioM Biotech Cluster Development GmbH, established in 2006, BioM coordinates the Munich Biotech Cluster, with the objective of turning it into a leading biotechnology center in Europe. They seek to foster an active cooperation between Bavarian research institutions and corporations. BioM actively invests seed capital in biotechnology startups in the Munich area, and manages a venture capital investment fund invested in high-growth early-stage businesses.